# Bicara Therapeutics Inc.: Form 8-K, filed Jun 12, 2025

- Company: [Bicara Therapeutics Inc.](/companies/bcax.md) (CIK 2023658)
- Form: 8-K
- Filed: 2025-06-12
- Accepted by EDGAR: Jun 12, 2025, 16:33 ET
- Period: 2025-06-09
- Accession: 0002023658-25-000082
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/bcax-20250609.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/bcax-20250609.htm

Filed Jun 12, 2025.
Source: SEC EDGAR, the filing index for accession 0002023658-25-000082. Last ingested by Listed: Nov 10, 2026, 02:09 ET. No prices; not investment advice.